InoCard Company
InoCard is a biotechnology company and develops AAV-based gene therapy approach for the long-term treatment of congestive heart failure.
Industry:
Gene Therapy
Technology:
Neurological Disorders
Headquarters:
Heidelberg, Baden-Wurttemberg, Germany
Founded Date:
2013
Funding Status:
M&A